Hrt Financial LP Amgen Inc Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $3.53 Million - $4.29 Million	13,439 New	13,439 $4.2 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $8.48 Million - $9.57 Million	33,164 New	33,164 $9.55 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $3.48 Million - $4.12 Million	16,255 New	16,255 $3.61 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $31.8 Million - $40.4 Million	138,789 New	138,789 $36.5 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $93 Million - $103 Million	403,127 Added 1079.0%	440,488 $107 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $7.09 Million - $7.84 Million	-32,317 Reduced 46.38%	37,361 $9.03 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $5.24 Million - $5.99 Million	26,333 Added 60.75%	69,678 $15.7 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $12.8 Million - $15 Million	-60,230 Reduced 58.15%	43,345 $9.22 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $24.2 Million - $26.8 Million	103,575 New	103,575 $25.2 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $1.94 Million - $2.38 Million	-9,805 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $1.79 Million - $2.37 Million	9,805 New	9,805 $1.99 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $822,685 - $1.06 Million	-4,348 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $4 Million - $4.8 Million	-23,001 Reduced 84.1%	4,348 $841,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $3.27 Million - $3.83 Million	19,615 Added 253.62%	27,349 $5.04 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $3.31 Million - $3.73 Million	-18,315 Reduced 70.31%	7,734 $1.47 Million
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $3.58 Million - $4.18 Million	20,090 Added 337.14%	26,049 $5.07 Million
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $639,621 - $721,088	3,452 Added 137.69%	5,959 $1.24 Million
Q2 2018 Aug 15, 2018	BUY	$166.05 - $186.51 $77,877 - $87,473	469 Added 23.01%	2,507 $462,000
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $130,969 - $153,054	773 Added 61.11%	2,038 $347,000
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $213,519 - $238,566	1,265	1,265 $219,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account